author-photo

Nadine Kutsch

University of Bonn

7

Papers

63

Citations

Citation Trend

Filter By

Papers (7) Sort By

Journal Conference Others

Mechanisms of Venetoclax Resistance in Chronic Lymphocytic Leukemia

2017 Blood
Show All
- Source
- Cite
- Save
Citations (3)
Mode of Progression after First Line Treatment Correlates with Outcome of Chronic Lymphocytic Leukemia (CLL)

2017 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Prognostic Impact of Immunohistochemistry and MRD Results in Bone Marrow after Frontline Chemoimmunotherapy of Chronic Lymphocytic Leukemia (CLL): Results of Central Laboratory Analyses of the CLL10 Trial of the German CLL Study Group (GCLLSG)

2017 Blood
Show All
- Source
- Cite
- Save
Citations (0)
FCR front-line therapy and quality of life in patients with chronic lymphocytic leukemia

2017 Leukemia & Lymphoma
Show All
- Source
- Cite
- Save
Citations (12)
Results of the Safety Run-in Phase of CLL14 (BO25323): A Prospective, Open-Label, Multicenter Randomized Phase III Trial to Compare the Efficacy and Safety of Obinutuzumab and Venetoclax (GDC-0199/ABT-199) with Obinutuzumab and Chlorambucil in Patients with Previously Untreated CLL and Coexisting Medical Conditions

2015 Blood
Show All
- Source
- Cite
- Save
Citations (23)
THE INTERNATIONAL PROGNOSTIC INDEX FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL-IPI)-AN INTERNATIONAL META-ANALYSIS

2015 Haematologica
Show All
- Source
- Cite
- Save
Citations (7)
The international Prognostic Index for patients with CLL (CLL-IPI): An international meta-analysis.

2015 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (18)